Viral clearance is not a new challenge for the biopharmaceutical industry. However, regulatory demand for better data combined with the growing recognition of the shortcomings of current virus removal and inactivation methods are fostering innovation, according to industry experts.
{iframe}https://www.genengnews.com/gen-articles/innovations-in-viral-clearance/6424{/iframe}